Wells Fargo’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,219
Closed -$52K 6676
2015
Q3
$52K Sell
1,219
-3,003
-71% -$127K ﹤0.01% 5254
2015
Q2
$179K Sell
4,222
-85,965
-95% -$3.63M ﹤0.01% 4675
2015
Q1
$3.5M Sell
90,187
-1,042
-1% -$40.1K ﹤0.01% 2625
2014
Q4
$3.07M Sell
91,229
-16,204
-15% -$572K ﹤0.01% 2709
2014
Q3
$3.76M Buy
107,433
+3,122
+3% +$107K ﹤0.01% 2536
2014
Q2
$3.43M Sell
104,311
-13,377
-11% -$458K ﹤0.01% 2613
2014
Q1
$4.34M Sell
117,688
-14,646
-11% -$537K ﹤0.01% 2412
2013
Q4
$5.08M Buy
132,334
+7,765
+6% +$245K ﹤0.01% 2253
2013
Q3
$3.41M Sell
124,569
-12,989
-9% -$308K ﹤0.01% 2485
2013
Q2
$2.89M Buy
+137,558
New +$2.69M ﹤0.01% 2539

Other funds holding WX

Wells Fargo's WX Position: Q4 2015 in Review

Wells Fargo sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,219 shares — an estimated $52K sold.

Wells Fargo first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $5.08M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Wells Fargo reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Wells Fargo sold 1,219 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $52K.
  • Wells Fargo first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Wells Fargo's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $5.08M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Wells Fargo's 13F filing for Q4 2015, filed 9 Feb 2016.